Changeflow GovPing Healthcare & Life Sciences Digital Mind-Body Therapy for Neoadjuvant Breas...
Routine Notice Added Final

Digital Mind-Body Therapy for Neoadjuvant Breast Cancer Trial

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

The National Institutes of Health has registered ClinicalTrials.gov study NCT07541664, a single-center, randomized controlled, prospective trial investigating Digital Mind-Body Therapy based on digital music and biofeedback during neoadjuvant treatment in patients with locally advanced breast cancer. The study lists neoadjuvant therapy as the condition and DMBT as the intervention. No compliance obligations or regulatory deadlines are associated with this study registration.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This entry adds a new ClinicalTrials.gov study record (NCT07541664) to the public registry. The trial will investigate Digital Mind-Body Therapy using digital music and biofeedback as an intervention during neoadjuvant treatment for locally advanced breast cancer patients. No regulatory obligations, reporting requirements, or compliance deadlines are created by this registration.

For clinical researchers and healthcare providers: this study registration may be relevant to institutional review boards assessing competing or complementary trial portfolios, and to patients seeking neoadjuvant breast cancer trial enrollment. The single-center, randomized controlled design with approximately 300 participants represents a modest addition to the mind-body intervention evidence base.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Digital Mind-Body Therapy for Neoadjuvant Breast Cancer

N/A NCT07541664 Kind: NA Apr 21, 2026

Abstract

This study is a single-center, randomized controlled, prospective trial investigating the application of Digital Mind-Body Therapy based on digital music and biofeedback (DMBT) during neoadjuvant treatment in patients with locally advanced breast cancer.

Conditions: Neoadjuvant Therapy

Interventions: DMBT

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Neoadjuvant therapy research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Clinical Operations Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!